CELLnTEC uses advanced insights into the biology of epithelial cells to develop precision epithelial culture media plus 2D & 3D in vitro models.
Location: Switzerland, Bern
Investors 3
Mentions in press and media 5
| Date | Title | Description |
| 21.02.2025 | International multi-million grants to tackle health and water challenges | ATANIS Biotech AG, a Bern-based start-up specializing in functional allergy tests, is the winner of phase 2 of the Innovation Award Diagnostic Challenge organized by FARE (Food Allergy Research & Education), the leading charity that su... |
| 02.08.2022 | 12 MedTech- Startups profitieren vom Booster-Programm | |
| 20.11.2020 | Ventures for the Virtual Venture Day revealed | |
| 20.11.2020 | Ventures for the Virtual Venture Day revealed | Organised by Startup INVEST, the Venture Day offers investors, business angels and corporate representatives a platform to connect with early and later-stage start-ups with deep tech solutions. The upcoming event will host around 200 guests... |
| 28.06.2013 | Biognosys and CELLnTEC looking for anti-aging substances |